Stefan Feuerstein, President About AMP German Cannabis Group AMP German Cannabis Group is licensed to import European Union – Good Manufacturing Practice (EU-GMP) medical cannabis from Europe and elsewhere into Germany. AMP sources, stores, transports, delivers, and sells medical cannabis products to pharmaceutical distributors or pharmacists directly, the only point-of-sale for medical cannabis to German patients with a physician’s prescription. Our strength is having front-line relationships with the distributors of medical cannabis to pharmacies, the only point-of-sale for medical cannabis to German patients, which allows us to respond to market changes quickly. To encourage the general discussion about cannabis, AMP released its first two of six episodes round table discussions about medical cannabis in Germany that are available by podcast or video. We do not expect the demand for cannabis products to be impacted by the effects of the pandemic in Germany next year.
Dear Shareholders,
The upcoming year will be transformational for AMP and the medical cannabis industry in Germany and globally.
AMP’s focus has always been to supply German patients with the highest quality cannabis products available. Our strength is having front-line relationships with the distributors of medical cannabis to pharmacies, the only point-of-sale for medical cannabis to German patients, which allows us to respond to market changes quickly.
In December 2020, the United Nations (UN) removed cannabis and cannabis resin from Schedule IV of the 1961 Single Convention on Narcotic Drugs, where it had been listed...
Read the full article @ Cannabis Law Report